Essential Points
· Most of the circulating testosterone is bound to its cognate binding proteins – sex hormone binding globulin (SHBG), human serum albumin (HSA), cortisol binding globulin, and orosomucoid. These binding proteins play an important role in regulating the transport, tissue delivery, bioactivity, and metabolism of testosterone.
· The physiochemical characteristics and dynamics of testosterone’s binding to its binding proteins are poorly understood. Over-simplified assumptions of stoichiometry, binding dynamics, and binding affinity have contributed to the development of inaccurate linear binding models of testosterone binding to SHBG and HSA
· The ensemble allosteric model of testosterone’s binding to SHBG developed from recent studies using modern biophysical techniques suggests that testosterone binding to SHBG is a complex, multistep process that involves inter-binding site allostery.
· The dynamics of testosterone’s binding to HSA, orosomucoid and CBG also require careful reexamination as the roles of these binding proteins in regulating circulating testosterone concentrations remain incompletely understood.
· If the free hormone hypothesis is correct, i.e. only the free testosterone is biologically active, accurate determination and harmonized reference ranges for free testosterone are necessary to diagnose androgen disorders in men and women.
· The methods for the measurement of free testosterone are fraught with potential problems including poor precision, inaccuracy, and specificity, and reliable assays are not readily available to practicing clinicians. Therefore, algorithms based on valid binding models that can be used to estimate the circulating free testosterone levels are needed to facilitate sound clinical decision making.
Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications. Endocr Rev. Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications | Endocrine Reviews | Oxford Academic
In circulation, testosterone and other sex hormones are bound to binding proteins which play an important role in regulating their transport, distribution, metabolism, and biologic activity. According to the free hormone hypothesis, which has been debated extensively, only the unbound or free fraction is biologically active in target tissues.
Consequently, accurate determination of the partitioning of testosterone between bound and free fractions is central to our understanding of how its delivery to the target tissues and biological activity are regulated, and, consequently, to the diagnosis and treatment of androgen disorders in men and women.
Here, we present an historical perspective of the evolution of our current understanding of testosterone's binding to circulating binding proteins. Based on an appraisal of the literature and new experimental data, we show that the assumptions of stoichiometry, binding dynamics, and binding affinity of the prevailing models of testosterone binding to sex hormone-binding globulin (SHBG) and human serum albumin (HSA) are not supported by the published experimental data and are likely inaccurate.
The review offers some guiding principles in the application of free testosterone measurements in the diagnosis and treatment of patients with androgen disorders. The growing number of testosterone prescriptions and the widely recognized problems with methods for the direct measurement as well as the computation of free testosterone concentrations render this critical review timely and clinically relevant.
· Most of the circulating testosterone is bound to its cognate binding proteins – sex hormone binding globulin (SHBG), human serum albumin (HSA), cortisol binding globulin, and orosomucoid. These binding proteins play an important role in regulating the transport, tissue delivery, bioactivity, and metabolism of testosterone.
· The physiochemical characteristics and dynamics of testosterone’s binding to its binding proteins are poorly understood. Over-simplified assumptions of stoichiometry, binding dynamics, and binding affinity have contributed to the development of inaccurate linear binding models of testosterone binding to SHBG and HSA
· The ensemble allosteric model of testosterone’s binding to SHBG developed from recent studies using modern biophysical techniques suggests that testosterone binding to SHBG is a complex, multistep process that involves inter-binding site allostery.
· The dynamics of testosterone’s binding to HSA, orosomucoid and CBG also require careful reexamination as the roles of these binding proteins in regulating circulating testosterone concentrations remain incompletely understood.
· If the free hormone hypothesis is correct, i.e. only the free testosterone is biologically active, accurate determination and harmonized reference ranges for free testosterone are necessary to diagnose androgen disorders in men and women.
· The methods for the measurement of free testosterone are fraught with potential problems including poor precision, inaccuracy, and specificity, and reliable assays are not readily available to practicing clinicians. Therefore, algorithms based on valid binding models that can be used to estimate the circulating free testosterone levels are needed to facilitate sound clinical decision making.
Goldman AL, Bhasin S, Wu FCW, Krishna M, Matsumoto AM, Jasuja R. A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications. Endocr Rev. Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications | Endocrine Reviews | Oxford Academic
In circulation, testosterone and other sex hormones are bound to binding proteins which play an important role in regulating their transport, distribution, metabolism, and biologic activity. According to the free hormone hypothesis, which has been debated extensively, only the unbound or free fraction is biologically active in target tissues.
Consequently, accurate determination of the partitioning of testosterone between bound and free fractions is central to our understanding of how its delivery to the target tissues and biological activity are regulated, and, consequently, to the diagnosis and treatment of androgen disorders in men and women.
Here, we present an historical perspective of the evolution of our current understanding of testosterone's binding to circulating binding proteins. Based on an appraisal of the literature and new experimental data, we show that the assumptions of stoichiometry, binding dynamics, and binding affinity of the prevailing models of testosterone binding to sex hormone-binding globulin (SHBG) and human serum albumin (HSA) are not supported by the published experimental data and are likely inaccurate.
The review offers some guiding principles in the application of free testosterone measurements in the diagnosis and treatment of patients with androgen disorders. The growing number of testosterone prescriptions and the widely recognized problems with methods for the direct measurement as well as the computation of free testosterone concentrations render this critical review timely and clinically relevant.
